Canadian Pharmacy Blog

According to new facts of Value in Health, the newer antipsychotic Zyprexa (Olanzapine) may not result in cost savings comparing with an older, inexpensive generic antipsychotic in treating of schizophrenia disease. It was revealed that despite higher medication costs of Zyprexa tablets the difference in one-year direct total costs between this [...]

A difficult topic has being discussed by the Committee of experts. The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) declared that Zyprexa (Olanzapine) drug is effective and safe in treating of schizophrenia or manic or mixed episodes associated with bipolar I disorder in patients aged 13-17 years [...]